Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Treatment of Opioid Dependence
NCT02548728Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in opioid use disorder (OUD), opioid withdrawal, sponsored by University of North Carolina at Chapel Hill. Started Feb 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
opioid use disorder (OUD)opioid withdrawal
Beyond the preview
Go deeper on NCT02548728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548728.